Geistlich Pharma AG (Switzerland), Zimmer Biomet Holdings, Inc. (US), Dentsply Sirona, Inc. (US) are the leading players in Dental Biomaterial Market
The global dental biomaterials market is projected to reach USD 9.6 billion by 2023 from USD 6.7 billion in 2018, at a CAGR of 7.4%. The increasing prevalence of dental disorders, rising geriatric population, growing dental tourism in developing countries, and increasing disposable income are the major factors driving the growth of this market. On the other hand, stringent regulatory and clinical processes are expected to restrain market growth to a certain extent. The global dental biomaterial market is consolidated at the top with the presence few big players in the market. However, there are many local, regional, and global players operating in this market, making it highly competitive. Straumann AG (Switzerland), Geistlich Pharma AG (Switzerland), Zimmer Biomet Holdings, Inc. (US), Danaher Corporation (US), Dentsply Sirona, Inc. (US), 3M Company (US), Royal DSM (Netherlands), Carpenter Technology Corporation (US), Kuraray Co., Ltd (Japan), Medtronic Plc. (Ireland), Henry Schein, In...